D. Plows et al., Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen, J IMMUNOL, 162(2), 1999, pp. 1018-1023
Collagen-induced arthritis in DBA/1 mice is a widely used experimental mode
l of rheumatoid arthritis. The induction phase of the disease is thought to
be dependent upon MHC-restricted T and B cell-mediated immune responses to
type II collagen, but an influence of additional non-MHC-restricted mechan
isms has also been proposed. In this study, we report that type II collagen
immunization of DBA/1 mice lacking mature T and B lymphocytes resulted in
the development of arthritic lesions, which were characterized by synovial
hyperplasia with occasional inflammation as well as cartilage and bone dest
ruction. The specificity of disease induction to type II collagen was confi
rmed, because arthritis could not be induced when control preparations of O
VA or adjuvant alone were administered. A delay in clinical disease onset a
nd a reduction in severity between lymphocyte-positive and -negative DBA/1
mice confirmed that lymphocytes play an important role in disease; however,
similar pathologic features and normal incidence suggest that lymphocyte-i
ndependent mechanisms of disease induction also operate in the standard col
lagen-induced arthritis model. We conclude that adaptive immune responses a
re not the only arthritogenic mechanism and hypothesize that the nonantigen
ic properties of type II collagen can also lead to arthritis.